FPE Capital LLP (‘FPE’), the specialist software & services focused lower mid-market growth investor, announces that their portfolio company Egress Group (‘Egress’) has acquired Stalis, specialists in healthcare data migration and archiving. Together, the two companies will offer a unique proposition to the healthcare sector – providing comprehensive end-to-end data management services and solutions.
Egress was FPE’s first investment from FPE Fund III, the firm’s third specialist software and services fund, the successful final close of which was announced in May 2022 at a raised hard cap of £185m. FPE’s investment in Egress was focused on leading the expansion of the management team and helping to accelerate growth within the sizeable and expanding UK market.
The acquisition brings together renowned providers in their respective data management fields, combining more than half a century’s experience working on large-scale, complex, multi-system change programmes. Stalis, 100% focused on healthcare since its inception in 1984, is best known as a leading supplier of data migration and data quality expertise, as well as archiving solutions, in this sector. This is complemented by Egress’s proven track record successfully delivering multiple healthcare system integration and interoperability programmes.
Llewellyn John, Partner at FPEWe are delighted to be welcoming Stalis into the Egress Group and are very excited about the synergy between the two organisations. The combined team represents the leading healthcare data management experts, with longstanding expertise across all major EPR vendors and systems and are both committed to advancing innovation in the healthcare sector by delivering unmatched end-to-end data management.
Joe Rooke, CEO of Egress GroupThe opportunity presented by combining the experience and track record of both Egress and Stalis is really special. Together, we can offer healthcare organisations true, end-to-end data management expertise, which is a unique proposition. Approaching all the data objectives of those organisations with one vision will be incredibly beneficial and, together, we can deliver that.
Kate, and the Stalis team, are a natural complement to our own organisation and staff. We share common values and company cultures, with like-minded individuals all passionate about what they do and the industries we work with.
Kate Bryan, Managing Director at StalisThis is an incredibly exciting next chapter for Stalis, which we believe will offer significant opportunities and very real benefits for our customers and also for all of our employees.
When we met Joe and the Egress team, it was obvious we all shared the same commitment to the healthcare sector, really wanting to make a difference to providers, their teams and, ultimately, the people they care for.
The NHS faces many challenges and data is one of the keys to unlocking real service transformation and innovation in care delivery. But those decisions and changes are only going to be as good as the data they are based upon. As a team, we understand this and will continue to support healthcare organisations to achieve complete data confidence throughout what are complex and challenging system change programmes.
Stalis will continue to operate as Stalis, with a complete focus on healthcare. No organisational changes are planned and all the senior leadership team, including Kate Bryan as MD, are remaining in post.
The transaction was led by Llewellyn John, Connor Trendell, Harriet Hunt and Harry Gill from FPE. Egress were advised on the transaction by Stephenson Harwood (Legal), Cortus Transaction Services (Financial), Tax Advisory Partnership (Tax) and Graph Strategy (Commercial). Headpoint Advisers advised the shareholders of Stalis.
